CO143 Impact of Investigational, at-Home, Self-Administered, Intranasal Etripamil on the Need for Additional Medical Intervention in Patients with Supraventricular Tachycardia von Pokorney, S.D., Camm, J.A., Dorian, P., Ip, J.E., Kowey, P.R., Stambler, B.S., Bharucha, D.B., Piccini, J.P.

Volltext

Antiarrhythmic medication for atrial fibrillation (AIM-AF) study: a physician survey of antiarrhythmic drug (AAD) treatment practices and guideline adherence in Europe von Blomstrom-Lundqvist, C, Camm, A.J, Goette, A, Kowey, P.R, Merino, J.L, Piccini, J.P, Reiffel, J.A, Saksena, S, Boriani, G

Volltext

JAMA: Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial von Kowey, P.R, Reiffel, J.A, Ellenbogen, K.A

Volltext

Supplementary Material for: Use of the HAVOC Score to Identify Patients at Highest Risk of Developing Atrial Fibrillation von M.S.V., Elkind, R., Wachter, A., Verma, P.R., Kowey, J.L., Halperin, B.J., Gersh, P.D., Ziegler, E., Pouliot, N., Franco, J.A., Reiffel

Volltext bestellen

Left ventricular hypertrophy increases vulnerability to bradycardia and D-sotalol induced early afterdepolarizations von Rials, S.J., Wu, Y., Liu, T., Xu, X., Bhatucha, D.D., Marinchak, R.A., Kowey, P.R.

Volltext